Company · CIK 0000799698 · SIC 2836 — Biological Products, (No Diagnostic Substances)
CYTRX CORP · CYTR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2017 AForm 4 → | Dec 19, 2:42 pm EST | Steven A KriegsmanCEO, Director | 387,597 | $1.75 | $678,295 | 387,597 | — | plan? |
| Dec 15, 2016 AForm 4 → | Dec 20, 7:31 pm EST | Steven A KriegsmanCEO, Director | 2,325,581 | $0.43 | $1,000,000 | 2,325,581 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2017 AForm 4 → | Jan 2, 2018, 5:27 pm EST | Felix KratzVice President Drug Discovery | 25,000 | — | — | 25,000 | — | late |
| Dec 15, 2017 AForm 4 → | Dec 19, 2:46 pm EST | Louis IgnarroDirector | 30,000 | — | — | 30,000 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 2:45 pm EST | John Y CalozChief Financial Officer | 58,334 | — | — | 58,334 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 2:44 pm EST | Joel K CaldwellDirector | 30,000 | — | — | 30,000 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 2:43 pm EST | Earl W BrienDirector | 70,000 | — | — | 70,000 | — | |
| Dec 15, 2017 AForm 4 → | Dec 19, 2:42 pm EST | Steven A KriegsmanCEO, Director | 208,334 | — | — | 208,334 | — | |
| Jul 12, 2017 AForm 4 → | Sep 6, 8:43 pm EDT | Joel K CaldwellDirector | 180,000 | — | — | 180,000 | — | late |
| Dec 15, 2016 AForm 4 → | Dec 20, 7:31 pm EST | Steven A KriegsmanCEO, Director | 1,250,000 | — | — | 1,250,000 | — | late |
| Dec 15, 2016 AForm 4 → | Dec 19, 2:32 pm EST | Daniel J LevittEVP and Chief Medical Officer | 400,000 | — | — | 400,000 | — | |
| Dec 15, 2016 AForm 4 → | Dec 19, 2:27 pm EST | Douglas Scott WielandSr VP - Drug Development | 150,000 | — | — | 150,000 | — | |
| Dec 15, 2016 AForm 4 → | Dec 19, 2:01 pm EST | John Y CalozChief Financial Officer | 350,000 | — | — | 350,000 | — | |
| Dec 15, 2016 AForm 4 → | Dec 19, 1:40 pm EST | Steven A KriegsmanCEO, Director | 1,250,000 | — | — | 1,250,000 | — | |
| Dec 15, 2016 AForm 4 → | Dec 19, 12:59 pm EST | Joseph RubinfeldDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2016 AForm 4 → | Dec 19, 12:49 pm EST | Louis IgnarroDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2016 AForm 4 → | Dec 19, 12:35 pm EST | Anita J ChawlaDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2016 AForm 4 → | Dec 19, 12:20 pm EST | Earl W BrienDirector | 180,000 | — | — | 180,000 | — | |
| Dec 2, 2016 AForm 4 → | Dec 6, 6:23 pm EST | Earl W BrienDirector | 180,000 | — | — | 180,000 | — | |
| Jan 11, 2016 AForm 4 → | Jan 14, 6:28 pm EST | Olivia C WareChief Commercial Officer | 350,000 | — | — | 350,000 | — | late |
| Dec 15, 2015 AForm 4 → | Dec 17, 1:01 pm EST | Douglas Scott WielandSr VP - Drug Development | 100,000 | — | — | 100,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 1:00 pm EST | Eric Jay SelterDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:58 pm EST | Joseph RubinfeldDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:56 pm EST | Ben LevinSVP-Legal Affairs/GC/Secy | 300,000 | — | — | 300,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:55 pm EST | Louis IgnarroDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:53 pm EST | Cheryl CohenDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:50 pm EST | Anita J ChawlaDirector | 180,000 | — | — | 180,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:49 pm EST | John Y CalozChief Financial Officer | 300,000 | — | — | 300,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:39 pm EST | Daniel J LevittEVP and Chief Medical Officer | 500,000 | — | — | 500,000 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 12:37 pm EST | Steven A KriegsmanCEO and Chairman of Board, Director | 1,000,000 | — | — | 1,000,000 | — |